Riskpilot← Back to searchSign inGet full accessNordic Kiropraktik AB
ABActiveOrg 5592024193Västmannagatan 66Physiotherapy activities · NACE 8695Est. 201911 employees
Revenue 2024
SEK 6,8M
+27% vs 2023
EBITDA margin
10.9%
-2% vs 2023
Equity ratio
39.3%
Financial strength
Net profit 2024
SEK 308K
-2% vs 2023
| Revenue | SEK 6,8M | +27% |
| EBITDA | SEK 739K | -2% |
| Net profit | SEK 308K | -2% |
| Total assets | SEK 2,5M | +29% |
| Equity | SEK 964K | -17% |
| Employees | 11 | — |
Legal name
Nordic Kiropraktik AB
Org number
5592024193
Legal form
Aktiebolag
NACE code
8695 · Physiotherapy activities
Founded
12 april 2019
Share capital
SEK 50 000
Employees
11 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva kiropraktor, naprapat- och friskvårds verksamhet, kurser samt utbildningar gentemot företag, privatpersoner och idrottsverksamhet. Därtill skall det även ske försäljning utav produkter inom dessa områden samt därmed förenlig verksamhet.
Address
Västmannagatan 66
Email
info@nordickiropraktik.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 365 | 1 807 | 3 894 | 5 364 | 6 793 |
| Staff expenses | — | — | −2 090 | −2 950 | — |
| EBITDA | 96 | 862 | 452 | 755 | 739 |
| Depreciation & amort. | −0 | −0 | −58 | −200 | −180 |
| EBIT | 96 | 862 | 395 | 556 | 559 |
| Net financials | — | — | −1 | −4 | −3 |
| Profit before tax | 96 | 862 | 394 | 406 | 403 |
| Tax | −26 | −181 | −94 | −92 | −95 |
| Net profit | 70 | 681 | 299 | 314 | 308 |
| Item | 2021 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 454 | 960 | 1 503 | 1 905 | 2 456 |
| Equity | 116 | 731 | 842 | 1 156 | 964 |
| Long-term debt | 288 | 0 | — | — | 0 |
| Short-term debt | 50 | 229 | 661 | 602 | 1 192 |
| Total debt | 338 | 229 | 661 | 602 | 1 192 |
EBITDA margin
10.9%
This company
15.8%
Market median
-31% vs market
20212024
Equity ratio
39.3%
This company
38.2%
Market median
+3% vs market
20212024
Return on equity
32.0%
This company
18.4%
Market median
+74% vs market
20212024
Net profit margin
4.5%
This company
8.1%
Market median
-44% vs market
20212024
Asset turnover
2.77×
This company
1.12×
Market median
+147% vs market
20212024
Debt / equity
1.55×
This company
0.62×
Market median
-150% vs market
20212024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-04-01 – 2021-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-04-01 – 2021-03-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
HE Chief Auditor | Chief Auditor | 2025 |
DA Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Nordic Kiropraktik AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Henrik Emil Brandt | Chief Auditor | 0 companies |
| Dani Alkhamisi | Chief Executive Officer | 0 companies |
| Madelen Alkhamisi Saaid | Deputy Board Member | 0 companies |